Data availability
All data presented in this article are totally available and present in the text.
References
Rivera C, Venegas B. Histological and molecular aspects of oral squamous cell carcinoma. Oncol Lett. 2014;8(1):7–11.
Norouzi A, et al. The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC). Oral Oncol. 2023;144:106483.
Law Z-J, et al. Extracellular vesicle-mediated chemoresistance in oral squamous cell carcinoma. Front Mol Biosci. 2021;8: 629888.
Park J-H, Schuchman EH. Acid ceramidase and human disease. Biochimica et Biophysica Acta (BBA) Biomembranes. 2006;1758(12):2133–8.
Morad SA, et al. Novel off-target effect of tamoxifen—inhibition of acid ceramidase activity in cancer cells. Biochimica et Biophysica Acta (BBA) Mol Cell Biol Lipids. 2013;1831(12):1657–64.
Roh J-L, et al. Targeting acid ceramidase sensitises head and neck cancer to cisplatin. Eur J Cancer. 2016;52:163–72.
Beckham TH, et al. Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials. Expert Opin Ther Targets. 2010;14(5):529–39.
Zalpoor H, et al. Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights. Cell Commun Signal. 2022;20(1):172.
Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):1–16.
Hippert MM, O’Toole PS, Thorburn A. Autophagy in cancer: good, bad, or both? Can Res. 2006;66(19):9349–51.
Salimi-Jeda A, et al. Autophagy modulation and cancer combination therapy: a smart approach in cancer therapy. Cancer Treat Res Commun. 2022;30: 100512.
Lai M, et al. Ablation of acid ceramidase impairs autophagy and mitochondria activity in melanoma cells. Int J Mol Sci. 2021;22(6):3247.
Turner LS, et al. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide. Prostate Cancer Prostatic Dis. 2011;14(1):30–7.
Aqbi HF, et al. Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy. Oncotarget. 2018;9(31):22113.
Kulkarni B, et al. Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. Oncotarget. 2020;11(20):1832.
Jo H, Shim K, Jeoung D. Roles of RNA methylations in cancer progression, autophagy, and anticancer drug resistance. Int J Mol Sci. 2023;24(4):4225.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
AN conceived the hypothesis. AN, FD, SMNV, and HZ wrote the manuscript. HZ edited the manuscript for important intellectual content and supervised the study. FD created the figure. FD and HZ revised the manuscript. All authors read and approved the final form of the article. AN and FD had equal contribution.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Norouzi, A., Davodabadi, F., Noorbakhsh Varnosfaderani, S. et al. The potential role of acid ceramidase in oral squamous cell carcinoma chemo-resistance by inducing autophagy. Human Cell 36, 2273–2275 (2023). https://doi.org/10.1007/s13577-023-00960-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-023-00960-0